Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
15 May 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/pathos-ai-secures-365m-series-d-fund-trial-novo-nordisk-solid-tumor-drug
08 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/08/3077172/0/en/Pathos-AI-Appoints-Iker-Huerga-as-Chief-Executive-Officer-to-Lead-the-Next-Era-of-AI-Enabled-Drug-Development.html
03 May 2025
// ENDPTS
https://endpts.com/pathos-ai-gets-astrazeneca-funding-as-biotech-plans-to-raise-up-to-400m/
23 Apr 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/tempus-ai-line-200m-astrazeneca-pathos-deal-develop-cancer-model
29 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/29/2970762/0/en/Pathos-AI-Closes-62M-Oversubscribed-Series-C-Round-of-Financing-to-Accelerate-its-Platform-Approach-to-Drug-Development.html
15 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/15/2930866/0/en/Pathos-Expands-Pipeline-With-Worldwide-License-of-Phase-2-ready-Brain-penetrant-PRMT5-Inhibitor.html
ABOUT THIS PAGE